Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
23.01
-0.96 (-4.01%)
At close: Sep 25, 2025, 3:59 PM
23.01
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-4.01% (1D)
| Bid | 22.5 |
| Market Cap | 3.08B |
| Revenue (ttm) | 15.95M |
| Net Income (ttm) | -230.37M |
| EPS (ttm) | -1.85 |
| PE Ratio (ttm) | -12.44 |
| Forward PE | -14.5 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 23.4 |
| Volume | 852,673 |
| Avg. Volume (20D) | 1,175,358 |
| Open | 23.89 |
| Previous Close | 23.97 |
| Day's Range | 22.86 - 23.89 |
| 52-Week Range | 9.60 - 24.13 |
| Beta | 1.48 |
| Ex-Dividend Date | n/a |
About CNTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCentessa Pharmaceuticals is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+15.64%
Centessa Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
-8.03%
Centessa Pharmaceuticals shares are trading lower on possible continued weakness after the company reported Q4 financial results on Monday and missed its EPS estimate.
